G. Dooijewaard

1.9k total citations
65 papers, 1.6k citations indexed

About

G. Dooijewaard is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, G. Dooijewaard has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cancer Research, 25 papers in Hematology and 14 papers in Molecular Biology. Recurrent topics in G. Dooijewaard's work include Protease and Inhibitor Mechanisms (36 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Blood properties and coagulation (13 papers). G. Dooijewaard is often cited by papers focused on Protease and Inhibitor Mechanisms (36 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Blood properties and coagulation (13 papers). G. Dooijewaard collaborates with scholars based in Netherlands, Germany and Italy. G. Dooijewaard's co-authors include E.C. Slater, Cornelis Kluft, G. T. Robillard, E.J.P. Brommer, J.J. Emeis, Walter Fiers, Jan H. Verheijen, VW van Hinsbergh, C. B. H. W. Lamers and Frans J. Leeuwerik and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Gastroenterology.

In The Last Decade

G. Dooijewaard

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Dooijewaard Netherlands 24 609 572 441 270 204 65 1.6k
Jean Marie Stassen Belgium 21 587 1.0× 758 1.3× 331 0.8× 472 1.7× 101 0.5× 55 1.7k
J.M. Foidart Belgium 16 753 1.2× 269 0.5× 736 1.7× 249 0.9× 583 2.9× 49 2.1k
Connie L. Erickson‐Miller United States 25 414 0.7× 1.2k 2.2× 678 1.5× 208 0.8× 237 1.2× 53 2.4k
Per Wallén Sweden 28 1.6k 2.6× 1.1k 1.9× 831 1.9× 827 3.1× 305 1.5× 60 2.8k
Louis Summaria United States 30 1.5k 2.5× 764 1.3× 997 2.3× 447 1.7× 569 2.8× 57 2.7k
Bart J.M. van Vlijmen Netherlands 26 315 0.5× 515 0.9× 661 1.5× 154 0.6× 213 1.0× 70 2.1k
J C Lormeau France 25 425 0.7× 980 1.7× 948 2.1× 175 0.6× 64 0.3× 52 2.8k
James R. Dilks United States 13 166 0.3× 434 0.8× 642 1.5× 426 1.6× 292 1.4× 23 1.5k
Mang Xiao China 24 300 0.5× 396 0.7× 732 1.7× 268 1.0× 343 1.7× 59 1.6k
R D Rosenberg United States 31 470 0.8× 2.1k 3.6× 810 1.8× 617 2.3× 128 0.6× 50 3.8k

Countries citing papers authored by G. Dooijewaard

Since Specialization
Citations

This map shows the geographic impact of G. Dooijewaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Dooijewaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Dooijewaard more than expected).

Fields of papers citing papers by G. Dooijewaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Dooijewaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Dooijewaard. The network helps show where G. Dooijewaard may publish in the future.

Co-authorship network of co-authors of G. Dooijewaard

This figure shows the co-authorship network connecting the top 25 collaborators of G. Dooijewaard. A scholar is included among the top collaborators of G. Dooijewaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Dooijewaard. G. Dooijewaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maat, Moniek P.M. de, G. Dooijewaard, Piet Meijer, et al.. (2001). Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study*. Blood Coagulation & Fibrinolysis. 12(6). 453–458. 2 indexed citations
2.
Huisman, L.G.M., et al.. (1996). Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator*. Clinical Pharmacology & Therapeutics. 60(5). 504–511. 12 indexed citations
3.
Boomsma, Dorret I., et al.. (1995). An Amino Acid Polymorphism in Histidine-rich Glycoprotein (HRG) Explains 59% of the Variance in Plasma HRG Levels. Thrombosis and Haemostasis. 74(6). 1497–1500. 10 indexed citations
4.
Levi, Marcel, et al.. (1994). Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood. Annals of Hematology. 68(1). 43–48. 11 indexed citations
5.
6.
Boer, Angela G. E. M. de, C. Kluft, J. Gerloff, et al.. (1993). Pharmacokinetics of Saruplase, a Recombinant Unglycosylated Human Single-Chain Urokinase-Type Plasminogen Activator and Its Effects on Fibrinolytic and Haemostatic Parameters in Healthy Male Subjects. Thrombosis and Haemostasis. 70(2). 320–325. 10 indexed citations
7.
Himmelreich, Gabriele, G. Dooijewaard, Wolf O. Bechstein, et al.. (1993). Evolution of Urokinase-Type Plasminogen Activator (u-PA) and Tissue-Type Plasminogen Activator (t-PA) in Orthotopic Liver Transplantation (OLT). Thrombosis and Haemostasis. 69(1). 56–59. 2 indexed citations
8.
Brommer, E.J.P., et al.. (1993). Parameters of Fibrinolysis in Peritoneal Fluid and Plasma in Different Stages of the Menstrual Cycle. Thrombosis and Haemostasis. 70(5). 873–875. 8 indexed citations
9.
Himmelreich, Gabriele, et al.. (1993). Changes in Urokinase-Type Plasminogen Activator in Orthotopic Liver Transplantation. Seminars in Thrombosis and Hemostasis. 19(3). 311–314. 4 indexed citations
10.
Boer, Angela G. E. M. de, Cornelis Kluft, G. Dooijewaard, et al.. (1992). Influence of Heparin and a Low Molecular Weight Heparinoid on Specific Endogenous and Exogenous Fibrinolytic Factors during Rest and Exercise. Thrombosis and Haemostasis. 68(5). 550–555. 10 indexed citations
11.
Dooijewaard, G., et al.. (1992). The Rationale of Prevention of Thrombosis by Enhancing Blood Levels of Single‐Chain Urokinase‐type Plasminogen Activator (scuPA). Annals of the New York Academy of Sciences. 667(1). 278–280. 1 indexed citations
12.
Briët, Ernest, et al.. (1992). Fibrinolytic System During Long-Distance Running in IDDM Patients and in Healthy Subjects. Diabetes Care. 15(8). 991–996. 23 indexed citations
13.
Levi, Marcel, Anthonie W.A. Lensing, Harry R. Büller, et al.. (1991). Deep Vein Thrombosis and Fibrinolysis. Thrombosis and Haemostasis. 66(4). 426–429. 8 indexed citations
14.
Loon, B.J. Potter van, et al.. (1990). Plasma plasminogen activator levels increase progressively during prolonged exercise. Fibrinolysis and Proteolysis. 4. 102–104. 1 indexed citations
15.
16.
Hinsbergh, Victor W.M. van, E.A. van den Berg, Walter Fiers, & G. Dooijewaard. (1989). Induction of urokinasetype plasminogen activator in human endothelial cells by inflammatory mediators. Fibrinolysis and Proteolysis. 3. 25–25. 1 indexed citations
17.
Griffioen, G, et al.. (1989). Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens. British Journal of Cancer. 60(3). 397–400. 9 indexed citations
18.
Kluft, Cornelis, H K Nieuwenhuis, D C Rijken, et al.. (1987). alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.. Journal of Clinical Investigation. 80(5). 1391–1400. 39 indexed citations
19.
20.
Dooijewaard, G. & E.C. Slater. (1976). Steady-state kinetics of low molecular weight (type-II) NADH dehydrogenase. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 440(1). 16–35. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Marie Stassen Breakdown of academic impact, for papers by J.M. Foidart Breakdown of academic impact, for papers by Connie L. Erickson‐Miller Breakdown of academic impact, for papers by Per Wallén Breakdown of academic impact, for papers by Louis Summaria Breakdown of academic impact, for papers by Bart J.M. van Vlijmen Breakdown of academic impact, for papers by J C Lormeau Breakdown of academic impact, for papers by James R. Dilks Breakdown of academic impact, for papers by Mang Xiao Breakdown of academic impact, for papers by R D Rosenberg
Rankless by CCL
2026